Wells Fargo & Company/Mn
—- Market cap
- $272.13B
- Debt
- +$193.04B
- Cash
- —
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 59% equity / 41% debt
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: WFC stock price at discount vs ROIV $89.99 current versus $88.25K implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ROIV's multiple
Implied fair value · at WFC's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: WFC FY 2025 (ended Dec 31, 2025) · ROIV FY 2026 (ended Mar 31, 2026). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 59% equity / 41% debt
Capital structure 98% equity / 2% debt · EV / Revenue 2586.72x
WFC carries the larger enterprise value at $465.16B against $21.37B; WFC trades on the lower EV / Revenue multiple (5.33x vs 2586.72x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
WELLS FARGO & COMPANY/MN · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
ROIVANT SCIENCES LTD. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
1.07x
0.09x
Net debt / EBITDA
Leverage against operating earnings
—
24.52x
Cash and equivalents
Liquid reserves on the balance sheet
—
$4.29B
Total debt
Interest-bearing obligations outstanding
$193.04B
$412.94M
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
JPMorgan Chase & Co.
WFC vs JPM
Bank of America Corporation
WFC vs BAC
Citigroup Inc.
WFC vs C
The Goldman Sachs Group, Inc.
WFC vs GS
Morgan Stanley
WFC vs MS
Capital One Financial Corporation
WFC vs COF
TRUIST FINANCIAL CORP
WFC vs TFC
Revolution Medicines, Inc.
WFC vs RVMD
INCYTE CORP
WFC vs INCY
Sarepta Therapeutics, Inc.
WFC vs SRPT
EXELIXIS, INC.
WFC vs EXEL
VERTEX PHARMACEUTICALS INC / MA
WFC vs VRTX
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.